Abstract The effectiveness of immunotherapy against glioblastoma (GBM) remains limited, suggesting that antigen-specific tumor-infiltrating lymphocytes (TILs) are rare. This study aimed to identify tumor-specific T cells in GBM as the basis for antigen-specific immunotherapy. Tumor specimens were collected from 56 patients newly diagnosed with IDH-wildtype GBM.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Isao
Contact Isao, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack